Federated Hermes sells 3,658 NERV shares

Federated Hermes Kaufmann Fund II reported a sale of 3,658 shares of Common Stock of NERV.

Rhea-AI Filing Summary

Federated Hermes Kaufmann Fund II reported a sale of 3,658 shares of Common Stock of NERV.

The filing shows the transaction date as 03/10/2026 and an aggregate amount of $29,331.18. The Form 144 notice lists prior "Securities To Be Sold" activity including a 17,225-share secondary/open-market entry dated 04/15/2015.

Key Figures

Shares sold: 3,658 shares Aggregate amount: $29,331.18 Securities to be sold (listed): 17,225 shares

3 metrics

Shares sold 3,658 shares sale dated 03/10/2026

Aggregate amount $29,331.18 associated with 3,658-share sale on 03/10/2026

Securities to be sold (listed) 17,225 shares listed under "Securities To Be Sold" dated 04/15/2015

Key Terms

Form 144, Secondary Offering/Open Market, Common Stock

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Secondary Offering/Open Market market

"Common Stock | 04/15/2015 | Secondary Offering/Open Market"

Common Stock financial

"Common Stock | Canaccord Genuity, Inc."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NERV Form 144 filing show?

It reports a resale notice for affiliate-held common stock. The excerpt shows Federated Hermes Kaufmann Fund II sold 3,658 shares on 03/10/2026 for $29,331.18, and lists a prior 17,225-share resale entry dated 04/15/2015.

Who sold NERV shares in this filing?

Federated Hermes Kaufmann Fund II is the seller shown. The record lines identify that entity and report a sale of 3,658 shares on 03/10/2026 with an aggregate figure of $29,331.18.

What transaction date and amount are disclosed in the NERV excerpt?

The disclosed transaction date is 03/10/2026 and the amount is $29,331.18. The entry pairs the date with a reported sale of 3,658 shares of common stock by Federated Hermes Kaufmann Fund II.

Does the filing show planned sales or past sales for NERV?

It shows a recent past sale and a separate listed resale entry. The recent sale is dated 03/10/2026 (3,658 shares), and a separate line lists 17,225 shares associated with 04/15/2015.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 05:00 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000912577
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	.Minerva Neurosciences Inc.
SEC File Number	001-36517
Address of Issuer	1601 Trapelo Road Suite 284 Waltham MASSACHUSETTS 02451
Phone	6176007373
Name of Person for Whose Account the Securities are To Be Sold	Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Canaccord Genuity, Inc. 1 Penn Plaza 30th Floor New York NY 10119	8798	70384.00	43274396	03/31/2026	NASDAQ
Common Stock	Instinet, Inc. 309 West 49th Street New York NY 10019	8798	70384.00	43274396	03/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/15/2015	Secondary Offering/Open Market	Unknown			17225	04/15/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Federated Hermes Kaufmann Fund II 4000 Ericsson Drive Warrendale PA 15086-7561	Common Stock	03/10/2026	3658	29331.18

144: Remarks and Signature

Remarks
Date of Notice	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Stephen Van Meter
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)